with their burden often extending to longer-term complications such as event recurrence and post-thrombotic syndrome (PTS). Few data exist on the overall economic burden of DVT and PE and their ...

If you have a clot in a deep vein, you're at risk for damage to your veins and organs as well as other life-threatening problems. Not everyone who gets DVT will have trouble, but there's a good ...

The COVID-19 pandemic has prompted the rapid development and administration of various vaccines worldwide, with some reports ...

Researchers at 37 sites in South Korea have found patients taking clopidogrel after percutaneous coronary intervention (PCI) ...

In subsequent animals, the addition of 100 units/kg heparin immediately before the antibody (days 0 and 2) reduced the incidence of thrombotic complications to just two (one renal artery ...

Bioxodes has enrolled first 16 patients in trial with BIOX-101 Completing treatment of first cohort of patients will trigger interim analysis BIOX-101 is a first-in-class drug candidate, a peptide ...

Kristof Vercruysse, Chief Executive Officer and co-founder of TargED, said: “The dosing of the first participant with our lead compound TGD001 marks a watershed in the treatment of thrombotic ...

In this retrospective analysis of a large-claims database that is representative of the U.S. commercially insured population, we investigated the annualized total reimbursed health care costs for ...